Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphine side effects in beta-arrestin 2 knockout mice.

Kirsten M Raehal1, Julia K L Walker, Laura M Bohn

  • 1Department of Pharmacology and Psychiatry, Ohio State University College of Medicine, Columbus, 43210-1239, USA.

The Journal of Pharmacology and Experimental Therapeutics
|May 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualitative beta-2-adrenoceptor signaling in the regulation of human airway epithelia mucin and cytokine production.

Respiratory research·2026
Same author

Triazole 187 is a biased KOR agonist that suppresses itch without sedation and induces anxiolytic-like behaviors in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Relationships between acculturative stressors and physiological stress response among Latinx immigrants in the southeastern United States.

Ethnicity & health·2025
Same author

Characterization of the GTPγS release function of a G protein-coupled receptor.

Nature communications·2025
Same author

GTP release-selective agonists prolong opioid analgesic efficacy.

Nature·2025
Same author

Exceptionally Potent Chiral Anandamide Analogs.

Journal of medicinal chemistry·2025

Altering beta-arrestin 2 regulation in mice enhances morphine analgesia while significantly reducing respiratory depression and constipation. This suggests a novel therapeutic target for opioid medications.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Genetics

Background:

  • Morphine is a powerful pain reliever but causes side effects like constipation and respiratory suppression, limiting its use.
  • Previous attempts to separate morphine's benefits from its harms via pharmacology have largely failed.
  • Opioid receptor regulation is complex and involves interactions with proteins like beta-arrestin 2.

Purpose of the Study:

  • To investigate if altering mu opioid receptor regulation can differentiate morphine's beneficial and harmful effects.
  • To examine the impact of beta-arrestin 2 deficiency on morphine-induced side effects in a mouse model.

Main Methods:

  • Utilized beta-arrestin 2 knockout mice, previously shown to have altered morphine responses.
  • Assessed analgesia, tolerance, respiratory suppression, and constipation in these genetically modified mice following morphine administration.

Related Experiment Videos

Main Results:

  • Beta-arrestin 2 knockout mice exhibited enhanced and prolonged morphine analgesia.
  • These mice developed minimal morphine tolerance.
  • Surprisingly, respiratory suppression and acute constipation induced by morphine were significantly attenuated in knockout mice.

Conclusions:

  • Genetic disruption of beta-arrestin 2-mediated opioid receptor regulation can separate morphine's analgesic effects from its major side effects.
  • Targeting beta-arrestin 2 pathways represents a novel strategy to develop safer and more effective opioid analgesics.
  • This finding opens new avenues for managing pain without compromising respiratory function or causing severe constipation.